Cole Swindell performed “Make Heaven Crowded” during an episode of “Fox & Friends” on Tuesday. The song is inspired by the death of Charlie Kirk, and the country music star performed it on what would ...

Investment Objective - The Scheme aims to generate returns by investing in portfolio of equity and debt schemes (including ETFs and Index Funds) as per the risk-return profile of investors. The Scheme ...

Another “record” for Taylor Swift: Her new album The Life of a Showgirl has become the first album ever to place all of its songs uninterrupted from the No. 1 to No. 12 spots on Billboard‘s Hot 100.

The 12th album from the pop star has landed atop the Billboard 200 chart, earning Swift her 15th No. 1 album, with all songs occupying the first 12 spots of the Billboard Hot 100. By Nicole Fell ...

The pop superstar sold four million copies of her latest album, topping a decade-old milestone by Adele. The tally included 1.3 million vinyl LPs. By Ben Sisario By the middle of last week, Taylor ...

Swift croons with purposeful millennial cringe on the fifth track of her 12th studio album, "The Life of a Showgirl" By Emily Rella Emily Rella is a Food Editor at PEOPLE. She has been working at ...

ADEL, Iowa — "We're your neighbors, we're your lifeline — we were living life before the call." That's a line from "Before the Call," a song meant to pay tribute to volunteer first responders like ...

Whether you're a California native, a transplant, or simply dream of living there, the world of music offers no shortage of tunes written in tribute to the Golden State. These songs span a wide range ...

Taylor Swift released her 12th album, The Life of a Showgirl, last week — and before it was even out for a full day, listeners were already pointing out similarities between her new songs and existing ...

Less than a week after Taylor Swift dropped her 12th studio album "The Life of a Showgirl," the Philadelphia Eagles alum broke down his and wife Kylie Kelce’s favorite tracks with brother Travis Kelce ...

Fintel reports that on October 8, 2025, Oppenheimer downgraded their outlook for Edwards Lifesciences (NYSE:EW) from Outperform to Perform. Analyst Price Forecast Suggests 17.07% Upside As of ...